• Phosphatase Inhibitor Cocktail: Workflow Guide

  2026-08-28

  Learn how a dual-component phosphatase inhibitor system preserves phosphorylation during lysis, immunoblotting, immunoprecipitation, kinase assays, and phosphoproteomics. The guide connects practical sample handling with recent evidence on ROS–ZAKα signaling in endometrial cancer and provides troubleshooting strategies for reproducible phospho-readouts.

• GCRV104 Entry: Clathrin-Mediated Endocytosis

  2026-08-27

  Wang et al. used pharmacological inhibition, transmission electron microscopy, and real-time qPCR to define how genotype III grass carp reovirus enters CIK cells. Their results identify a dynamin-dependent, acidification-sensitive clathrin pathway while showing that latrunculin B-sensitive actin polymerization is not required under the tested conditions.

• Alpha-Ketoglutarate Assays in Tumor Metabolism

  2026-08-27

  Alpha-ketoglutarate is more than a TCA-cycle intermediate: it is a controllable variable linking carbon flux, nitrogen handling, and macrophage function. This assay-focused guide translates recent cholangiocarcinoma findings into practical experimental decisions without confusing metabolite supplementation with endogenous metabolic accumulation.

• ALDH2 Activation Delays Pressure-Overload Heart Failure

  2026-08-26

  A 2025 Experimental Cell Research study shows that activating ALDH2 can extend the postnatal proliferative window of mouse cardiomyocytes and enhance cardiomyocyte proliferation in adult mice exposed to pressure overload. The findings position ALDH2 as a potential link between aldehyde detoxification, cardiac stress responses, and myocardial regeneration, while leaving important questions about mechanism, durability, and human translation unresolved.

• SCH772984: Designing Rigorous ERK1/2 Assays

  2026-08-26

  SCH772984 is a selective ERK1/2 inhibitor for dissecting MAPK signaling in mutant cancer models. This guide connects biochemical potency with phospho-signaling, ferroptosis, radioresistance, and in vivo assay design without overstating evidence.

• Arachidonic Acid and Rapid Vaccine Immunity

  2026-08-25

  A 2025 study reported that dietary arachidonic acid enhanced rabies vaccine-induced neutralizing antibodies and improved protection in mice, while oral supplementation accelerated protective antibody development in human volunteers. The work links lymph-node arachidonic acid metabolism to a prostaglandin I2–cAMP–PKA pathway involving CD86 and activation-induced cytidine deaminase, suggesting a dietary route for strengthening germinal-center responses.

• One-step TUNEL Cy5 Apoptosis Detection Kit Workflow

  2026-08-25

  Apply Cy5-based DNA fragmentation detection across osteonecrosis models, tissue sections, and cultured cells with a workflow designed for spatial imaging or flow cytometry. This guide connects the One-step TUNEL Cy5 Apoptosis Detection Kit to the PTX3–TLR4/NF-κB/FGF21 findings in a recent osteonecrosis study while emphasizing controls, optimization, and interpretation limits.

• Cinoxacin: Mechanism, Spectrum, and Clinical Evidence

  2026-08-24

  The reference paper integrates Cinoxacin’s DNA synthesis inhibition, antibacterial spectrum, pharmacokinetics, adverse reactions, and clinical performance in urinary tract infections. Its central contribution is to define Cinoxacin as a urinary-focused quinolone antibiotic with activity against important Enterobacteriaceae, while clarifying resistance overlap, renal elimination, and limitations against Pseudomonas and Gram-positive organisms.

• N-Formimidoyl Thienamycin vs β-Lactams: 1982 Study

  2026-08-23

  Cullmann and colleagues compared N-formimidoyl thienamycin (MK0787) with several contemporary β-lactam antibiotics across 470 clinical isolates, emphasizing resistant Enterobacteriaceae, nonfermenting gram-negative organisms, and selected gram-positive bacteria. The study showed that MK0787 combined broad antibacterial activity with strong bactericidal behavior against gram-negative isolates and activity that was largely independent of β-lactamase production.

• BMS-777607 Workflow for c-Met Inhibition

  2026-08-22

  BMS-777607 supports a dual research strategy: mechanistic MET signaling pathway inhibition in cancer models and exploratory small-molecule testing in hiPSC-derived megakaryocyte workflows. This guide separates validated product evidence from assay-development recommendations to improve reproducibility, interpretation, and troubleshooting.

• Epalrestat: From Polyol Pathway to Parkinson’s

  2026-08-21

  Epalrestat is an aldose reductase inhibitor with emerging relevance to oxidative stress research and Parkinson’s disease models. This article translates the latest KEAP1/Nrf2 findings into a practical, tiered assay strategy while clarifying material handling and translational limits.

• Ganetespib (STA-9090): Assay Q&A

  2026-08-21

  A scenario-based guide to using Ganetespib (STA-9090), SKU A4385, in cell viability, proliferation, and cytotoxicity workflows. It connects Hsp90 mechanism, solvent handling, exposure design, orthogonal readouts, and vendor-selection criteria to improve interpretation in cancer research.

• Cirsium setidens Protects Against Doxorubicin Cardiotoxicity

  2026-08-20

  A July 2024 Phytomedicine study found that a hydroethanolic extract of Cirsium setidens reduced doxorubicin-associated mitochondrial injury and cardiac dysfunction through an AMPK–PGC-1α–NRF1–SOD pathway. Its use of cardiomyocyte, breast cancer, mouse, and human iPSC-derived cardiac models supports a mechanistically grounded strategy for separating cardioprotection from loss of anticancer activity.

• HPF for Highly Reactive Oxygen Species Detection

  2026-08-20

  HPF (hydroxyphenyl fluorescein) provides a selective green-fluorescence readout for hydroxyl radicals and peroxynitrite in live-cell assays. This guide translates that chemistry into microscopy, plate-reader, flow-cytometry, and multimodal phototherapy workflows, with practical controls and troubleshooting advice.

• L-Alanyl-L-Glutamine for Barrier Assay Workflows

  2026-08-19

  Build more controlled intestinal barrier experiments with a stable, water-soluble L-Ala-L-Gln dipeptide and clearly defined handling steps. The workflow also shows how to use it as a nutritional and cell-state control when adapting antiviral screening concepts without overstating antiviral activity.

444 records 6/30 page Previous Next First page 上5页 678910 下5页 Last page